Real-world Study of Patients with Metastatic Colorectal Cancer Receiving Investigational Bevacizumab in Combination with TAS-102 in the Third or Posterior Line
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/81138
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: Group 1:Bevacizumab combined with TAS-102
Primary outcome(s): overall survival;disease progress free survival
Study Design: Single arm
创建时间：
2022-11-15
